JANINE RUSSELL: Open Payments
NPI 1881234516 · KINSTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 23 payments from 8 companies in 2025. Trend: 2023 $597 · 2024 $313 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $339 |
| Luye Pharma (USA) Ltd. | 1 | $124 |
| Neurocrine BioSciences, Inc. | 4 | $84 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Indivior Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: VRAYLAR, ERZOFRI EXTENDED-RELEASE, INGREZZA, SPRAVATO, SUBLOCADE, REXULTI, COBENFY, AUSTEDO XR.
Industry payments across NC — which companies pay providers there.
